Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: Correlations with cognitive impairment

Brain Research

Volumn 926, Issue 1-2, 2002, Pages 58-68

  King, David L ^a   Arendash, Gary W ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; Correlations with cognition; Synaptophysin staining; Transgenic mouse

Indexed keywords

AMYLOID BETA PROTEIN; SYNAPTOPHYSIN;

AGING; AGNOSIA; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NEOCORTEX; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION; TASK PERFORMANCE; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOCORTEX; SYNAPSES; SYNAPTOPHYSIN;

EID: 0036468268     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)03294-2     Document Type: Article

References (50)

1. Plasticity of the synaptic contact zone following loss of synapses in the cerebral cortex of aging human
2. Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice
3. Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration
4. Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions
5. Neuron loss in APP transgenic mice
6. Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice
7. Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice
8. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
9. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein
10. A behavioural analysis of rats with damage to the medial prefrontal cortex using the Morris water maze: Evidence for behavioural flexibility, but not for impaired spatial navigation
11. Structural correlates of cognition in dementia: Quantification and assessment of synapse change
12. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
13. Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice
14. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein
15. Microglial response to amyloid plaques in APPsw transgenic mice
16. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein
17. Neuroanatomic correlates of visual agnosia in Alzheimer's disease: A clinicopathologic study
18. Synaptic loss in Alzheimer's disease and other dementias
19. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phoneomenon in Alzheimer's disease
20. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
21. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits
22. Regional synaptic pathology in Alzheimer's disease
23. Tissue fixation methods alter the immunohistochemical demonstrability of synaptophysin
24. Correlative memory deficits, abeta elevation, and amyloid plaques in transgenic mice
25. Long-lasting forms of synaptic potentiation in the mammalian hippocampus
26. Perforant pathway changes and the memory impairment of Alzheimer's disease
27. APPsw transgenic mice develop age-related A beta deposits and neurophil abnormalities, but no neuronal loss in CA1
28. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse
29. Progressive and gender-dependent cognitive impairment in the APPsw transgenic mouse model for Alzheimer's disease
30. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months
31. Synaptic pathology in Alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles
32. Blink rats are not profoundly impaired in the reference memory Morris water maze and cannot be clearly discriminated from rats with cognitive deficits in the cued platform task
33. Quantitative immunohistochemistry of synaptophysin in human neocortex: An alternative method to estimate density of presynaptic terminals in paraffin section
34. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease
35. The synaptic organization of the neocortex in Alzheimer's disease
36. Synaptic and neuritic alterations during the progression of Alzheimer's disease
37. Novel domain-specific actions of amyloid precursor protein on developing synapses
38. Place navigation impaired in rats with hippocampal lesions
39. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions
40. Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice
41. High-level neuronal expression of Abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation
42. Adaptation of the circular platform spatial memory task for mice: Use in detecting cognitive impairment in the APPsw transgenic mouse model for Alzheimer's disease
43. Cell-surface beta-amyloid precursor protein stimulates neurite out growth of hippocampal neurons in an isoform-dependent manner
44. Synapse loss in the temporal lobe in Alzheimer's disease
45. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease
46. Differential expression of rat brain synaptic proteins in development and aging
47. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease
48. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss
49. Amyloid precursor protein potentiates the neurotrophic activity of NGF
50. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes